Search results
What To Know and Do About Eye Pain
Health via Yahoo News· 7 hours agoIf you don't notice your eye pain getting better, speak with your healthcare provider about options for treatment. Corneal Abrasion Corneal abrasion is...
What it means if your fingers get numb or tingle
Rolling Out· 1 day agoHave you ever experienced a sensation where your fingers get numb or tingle? This phenomenon can be alarming and uncomfortable. Understanding what it...
LVHN Health Tips: 5 things you should know about Lyme Disease | Times News Online
Times News· 5 days agoAlthough Pennsylvania is home to plenty of beautiful places to hike and camp, it’s also home to a number of bugs, including deer ticks, which transmit Lyme disease. Dr. Knouse says there are ...
Nektar Therapeutics (NASDAQ:NKTR) Director Sells $23,400.00 in Stock
ETF DAILY NEWS· 14 hours agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) Director Robert Chess sold 19,500 shares of Nektar Therapeutics stock in a transaction on Friday, June 14th. The shares were sold at an average ...
Mouth Ulcer
Health via Yahoo News· 2 days agoHealth conditions like inflammatory bowel disease (IBD) and systemic lupus erythematosus (an autoimmune disease that affects healthy tissue) can cause...
HRT patches, gels and tablets – which is best for you?
Daily Telegraph· 4 days ago“If you’re a slim, healthy young woman with no medical conditions, you could probably choose any...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 7 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
FierceBiotech· 6 days agoSpecifically, Alumis plans to use part of the IPO haul to advance the development of its lead asset,...
Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase...
FOX 23 News Albany· 2 days agoJohnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically...
